BIO-key International Inc. (NASDAQ:BKYI) Sees Large Increase in Short Interest

BIO-key International Inc. (NASDAQ:BKYI) was the recipient of a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 63,876 shares, an increase of 4,465.8% from the July 15th total of 1,399 shares. Currently, 6.1% of the shares of the company are sold short. Based on an average daily volume of 231,601 shares, the short-interest ratio is presently 0.3 days.

BIO-key International Trading Down 6.5%

Shares of BIO-key International stock traded down $0.27 during trading hours on Tuesday, reaching $3.90. 87,100 shares of the company’s stock were exchanged, compared to its average volume of 169,180. The company has a fifty day moving average of $4.39 and a 200-day moving average of $5.30. BIO-key International has a 52-week low of $3.10 and a 52-week high of $19.70. The firm has a market capitalization of $4.24 million, a price-to-earnings ratio of -0.70 and a beta of 0.44.

Hedge Funds Weigh In On BIO-key International

A hedge fund recently raised its position in BIO-key International stock. Geode Capital Management LLC raised its holdings in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,892 shares of the technology company’s stock after buying an additional 16,271 shares during the period. Geode Capital Management LLC owned about 0.45% of BIO-key International worth $26,000 at the end of the most recent reporting period. Institutional investors own 26.51% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on BKYI shares. Zacks Research raised BIO-key International to a “hold” rating in a report on Thursday, August 6th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a research note on Friday, July 17th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Reduce”.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.